The CDMO FUJIFILM Biotechnologies is in the midst of a growth upswing, with about $7 billion in expansion projects underway across the United States and Europe. The centerpiece is its $3.2 billion Holly Springs, North Carolina site, whose first phase came online in September 2025. A second phase is slated for around 2028. In Denmark, the company is expanding its Hillerød campus with another eight 20,000-liter bioreactors and two new downstream streams, and in early 2026 it opened the UK’s…
